phenylpropanolamine has been researched along with Urinary Tract Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wyndaele, JJ | 1 |
| Athanasopoulos, A; Perimenis, P | 1 |
| Loeven, KO | 1 |
| Layton, D; Pearce, GL; Shakir, SA | 1 |
1 review(s) available for phenylpropanolamine and Urinary Tract Diseases
| Article | Year |
|---|---|
Efficacy of the combination of an alpha1-blocker with an anticholinergic agent in the treatment of lower urinary tract symptoms associated with bladder outlet obstruction.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Benzhydryl Compounds; Benzilates; Cholinergic Antagonists; Cresols; Doxazosin; Drug Therapy, Combination; Humans; Male; Phenylpropanolamine; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder Neck Obstruction; Urinary Incontinence; Urodynamics; Urologic Diseases | 2005 |
3 other study(ies) available for phenylpropanolamine and Urinary Tract Diseases
| Article | Year |
|---|---|
Editorial comment on: Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size.
Topics: Adrenergic alpha-Antagonists; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Male; Muscarinic Agonists; Organ Size; Phenylpropanolamine; Prostate; Safety; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder Neck Obstruction; Urinary Bladder, Overactive; Urologic Diseases | 2009 |
Questions use of phenylpropanolamine in animals with obstructive urinary disease.
Topics: Animals; Ferrets; Male; Phenylpropanolamine; Sympathomimetics; Urologic Diseases | 1996 |
Safety profile of tolterodine as used in general practice in England: results of prescription-event monitoring.
Topics: Benzhydryl Compounds; Cohort Studies; Cresols; Drug Monitoring; England; Family Practice; Female; Hallucinations; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Surveys and Questionnaires; Tachycardia; Tolterodine Tartrate; Urologic Diseases | 2001 |